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ABSTRACT
The MiniChromosome Maintenance 2-7 (MCM2-7)
complex provides essential replicative helicase
function. Insufficient MCMs impair the cell cycle
and cause genomic instability (GIN), leading
to cancer and developmental defects in mice.
Remarkably, depletion or mutation of one Mcm
can decrease all Mcm levels. Here, we use mice
and cells bearing a GIN-causing hypomophic allele
of Mcm4 (Chaos3), in conjunction with disruption
alleles of other Mcms, to reveal two new mechan-
isms that regulate MCM protein levels and pre-RC
formation. First, the Mcm4
Chaos3 allele, which
disrupts MCM4:MCM6 interaction, triggers a
Dicer1 and Drosha-dependent  40% reduction in
Mcm2–7 mRNAs. The decreases in Mcm mRNAs
coincide with up-regulation of the miR-34 family of
microRNAs, which is known to be Trp53-regulated
and target Mcms. Second, MCM3 acts as a negative
regulator of the MCM2–7 helicase in vivo by com-
plexing with MCM5 in a manner dependent upon a
nuclear-export signal-like domain, blocking the re-
cruitment of MCMs onto chromatin. Therefore, the
stoichiometry of MCM components and their local-
ization is controlled post-transcriptionally at both
the mRNA and protein levels. Alterations to these
pathways cause significant defects in cell growth
reflected by disease phenotypes in mice.
INTRODUCTION
In eukaryotes, the amount and timing of DNA replication
are tightly controlled to conduct a single genome replica-
tion during S phase (1). Perturbations of the replication
machinery can alter ploidy, genome stability and the cell
cycle. In late mitosis to early G1, replication machinery
assembles at numerous locations (replication ‘origins’) in
the genome to form a pre-replicative complex (pre-RC).
The process begins with binding of the Origin Recognition
Complex (ORC) to origins, followed by CDC6 and CDT1
which load the MCM2–7 replicative helicase, then other
factors needed for helicase activity and competence
(‘licensing’) to initiate DNA replication (1). Although
cells contain far more MCM2–7 protein than is required
to complete DNA replication, excess chromatin-bound
MCM2–7 complexes occupy dormant or ‘backup’
origins that can be activated to complete DNA replication
near stalled or disrupted primary replication forks (2–4).
Humans with mutations in any of several pre-RC compo-
nents are afﬂicted with a severe developmental syndrome
known as Meier-Gorlin (5–7). Mice with decreased (40%
or more) MCM levels are susceptible to genomic instabil-
ity (GIN), cancers and developmental defects (8–10) due
to fewer backup origins (11).
While these studies demonstrate that proper homeosta-
sis of the DNA-licensing process is critical for health, little
is known about the regulation of these factors in
mammals. However, multiple studies in cultured cells
and mice reported a phenomenon whereby genetic- or
siRNA-induced depletion of a single MCM causes deple-
tion of the other MCMs (3,4,8,9,11–14). It was generally
assumed that the pan-decreases were due to MCM2–7
hexamer destabilization. However, single MCM
knockdown in Drosophila, induced MCM2–7 instability
in human cultured cells, and a hypomorphic allele of the
mouse Mcm4 (Mcm4
Chaos3) all showed an mRNA
pan-down-regulation coordinate with decreased protein
levels (10,15,16). The underlying mechanism is unknown.
DNA replication can also be regulated at the level of
pre-RC component loading. Studies in yeast indicate that
all six MCMs (MCM2–7) can load onto replication
origins as a ring-shaped toroidal heterohexamer, and
there is substantial evidence that this constitutes the
eukaryotic replicative helicase (17). However, MCM4/6/
7 are typically co-isolated during biochemical puriﬁcations
as a subcomplex, either as trimers or double trimers
(MCM4/6/7)2 with in vitro helicase activity. Analyses of
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the ‘core’ helicase (17–20), whereas MCM3/5 dimers
provide negative regulatory function (21,22). We previ-
ously found that genetic reduction of MCM3 ameliorates
numerous mutant phenotypes exhibited by mice and cells
depleted for other MCMs, including cancer susceptibility,
embryonic lethality and defective cell cycle/proliferation
(10). Paradoxically, this rescue by MCM3 depletion
occurred by increasing the amounts of chromatin-bound
MCM2–7 in vivo, and thus may work by modulating
loading of pre-RC components.
In this study, we exploit the Mcm4
Chaos3 model to reveal
two novel mechanisms for post-transcriptional regulation
of replication licensing in vivo. One occurs at the mRNA
level and is modulated by the small RNA regulatory
pathway to trigger pan-down-regulation of all Mcms.
This suggests the existence of a novel regulatory relation-
ship for governing the stoichiometry of the MCM
DNA-replication licensing complex in response to replica-
tion stress or other situations. The other mechan-
ism involves negative regulation of MCM2–7 access to
chromatin by a MCM3:MCM5-containing complex.
Furthermore, these in vivo studies provide insight into
the relevance of in vitro experiments on the function of
MCM complexes in whole organisms.
MATERIALS AND METHODS
Lentiviral expression vectors
Doxycycline inducible lentiviral vectors (23) were
prepared by co-transecting viral packaging plasmids
psPAX2 and pMD2.G with vectors encoding rtTA,
LacZ, Mcm2, Mcm3, Mcm4 or Mcm3 mutant into 293T
cells using TransIT-Lt1 transfection reagent (Mirus). Viral
supernatants were collected at 48 and 72h and
concentrated. Mouse embryonic ﬁbroblasts (MEFs;
P1–P3) seeded at 6.75 10
3cells/cm
2 and incubated for
24h were infected with lentiviral vectors. After 24h,
2mg/ml doxycycline (Sigma) was added, and the cells
were cultured for 5 days before ﬂow cytometric analysis
(described below). For HeLa cell infection, 1000 cells were
seeded into 150mm tissue culture dishes and cultured for
14 days before infection. Plates were ﬁxed and colonies
visualized with Crystal Violet.
Protein and cellular fractionation
A Triton-100 based fractionation of chromatin-bound
versus non-chromatin-bound proteins was used. In this
protocol, nuclei pelleted from lysed cells contained
nuclear scaffold proteins, DNA and chromatin binding
forms of MCMs. The supernatant (detergent soluble
fraction, referred to in the text as ‘soluble’ versus the chro-
matin bound or ‘extracted’ proteins) contained proteins of
the cell membrane, cytosol and free forms of MCMs
(4,24). For protein extraction, the nuclear pellet was
washed twice with 1ml TX-NE (320mM sucrose,
7.5mM MgCl2, 10mM HEPES, 1% Triton X-100 and a
protease inhibitor cocktail) and resuspended in 0.5ml
RIPA. Successful partitioning was assessed not only
with Western blotting controls, but with ﬂow cytometric
analysis of detergent-extracted whole nucleus preps
(Supplementary Figure S1a), which were consistent
with prior studies (25).
MEF culture
Mouse embryonic ﬁbroblasts (MEFs) from 12.5- to
14.5-dpc embryos were cultured in Dulbecco’s-Modiﬁed
Eagle’s Medium (DMEM) supplemented with 10% FBS,
2mM GlutaMAX, penicillin–streptomycin (100U/ml)
and b-mercaptoethanol. All assays were conducted on
cells at early passages (up to 2–3 weeks after initial isola-
tion from embryos).
RNA interference
ON-TARGETplus SMARTpool small interfering RNA
(siRNA) was purchased from Dharmacon (Lafayette,
CO, USA). MEFs were seeded on six-well plates at
1 10
5 cells/well and grown for 12h. The cells were then
transfected with siRNAs against mouse DicerI (Mix of G
GUAGACUGUGGACCGUUU, GGAAAUACCUGU
ACAACCA, GCAAUUUGGUGGUUGGUUU and A
CAGGAAUCAGGAUAAUUA), Drosha (UGGAAGG
AGUUACGCUUUA, GCCAAAUACGGAUCGGCA
A, UGUGUAAAGUGAUUCGAUU and GGAUGGA
AUUUCUGGGCGA), or an unrelated scrambled
siRNA (CCUACUAAGCGACACCAUUdTdT) at a
ﬁnal concentration of 100nM using DharmaFECT1
(Dharmacon). After 24h, the transfection medium was
replaced with DMEM. The cells were harvested 96 or
120h post-transfection for qRT-PCR analysis.
Micronucleus assays
These were performed essentially as described (26).
Chromatin immunoprecipitation assays
Mouse embryonic ﬁbroblasts (MEFs) were plated at
4 10
6 cells/150mm culture plate for 60h, then treated
for 10min at room temperature in 1% formaldehyde to
crosslink chromatin proteins to DNA. The reaction was
stopped with 0.125M glycine for 5min. Cells were pelleted
and resuspended in 1ml sonication buffer (Upstate) for
10min on ice. About 450ml were sonicated to generate
500-bp fragments on average (300–700bp). A total of
100mg of DNA–chromatin complexes were processed
according to the EZ ChIP
TM (Upstate) kit protocol.
Monoclonal anti-RNA polymerase II (phospho S2;
Covance) and rabbit anti-mouse IgM antibody
(Millipore) were incubated together for immunopre-
cipitation. DNA was puriﬁed by phenol–chloroform
extraction and ethanol precipitation.
For quantitative PCR analysis of RNA polymerase
II-bound targets, the immunoprecipitated (IP’d) DNA
was resuspended in 100ml of water. Input DNA was
used as reference.
Co-immunoprecipitation
Cells (1 10
6) were transfected with an expression plas-
mid using Lipofectamine 2000 (Invitrogen). After 72h,
total protein was extracted using RIPA buffer (50mM
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1mM EDTA, 0.5% Sodium Deoxycholate and 50mM
NaF) with protease inhibitor (Protease Inhibitor Cocktail
Tablets, Roche Cat. No. 11836153001). After centrifuga-
tion (10000g for 10min), the supernatant was incubated
with primary antibody at 4 C overnight and then with
Protein A Agarose (Millipore, Cat. No. 16-125) at room
temperature for 1h, followed by three washes in RIPA.
Bound proteins were denatured by boiling in sample
buffer and used for SDS–PAGE and western blotting.
For detecting ecotopic Mcm4 variants in HEK cells,
anti-FLAG (Sigma F3165) was used. For reciprocal
co-IP experiments, anti-MCM6 (Santa Cruz sc-9843)
and anti-MCM7 (Cell Signaling #4176) were used.
Western blot analysis
The concentration of protein samples were quantiﬁed with
a BCA kit (Pierce). Fifteen micrograms of total protein
were separated by SDS–PAGE, electrotransferred onto a
pure nitrocellulose membrane (Bio-Rad), and probed with
the relevant antibodies. Binding was detected with a Pierce
ECL kit and autoradiography. For quantifying immuno-
blotting, ECL bands on the ﬁlm were scanned (grayscale
at 800dpi), saved as TIFF images, and ImageJ
software (http://rsb.info.nih.gov/ij/) was used to create
an Integrated Density Value (IDV) for each band.
Background correction was done using a ‘rolling ball’
method with a radius of four times the width of a band.
The antibodies used were as follows: MCM2: ab31159
(Abcam); MCM3: 4012 (Cell Signaling); MCM4: ab4459
(Abcam); MCM5: NB100-78261 (Novus); MCM6:
NB100-78262 (Novus); MCM7: ab2360 (Abcam); MYC:
Mouse Monoclonal Anti-c- Myc M4439 (Sigma); FLAG:
Rabbit Polyclonal Anti-FLAG #2368 (Cell Signaling);
Fibrillarin: ab5821 (Abcam) GAPDH: 6C5 (Advanced
Immunochemical); and b-actin: A1978 (Sigma).
Luciferase constructs and assays
The promoter regions of Mcm2, Mcm5, Mcm7 and Pgk2
(300-bp upstream of the annotated transcriptional start
sites) were PCR ampliﬁed from mouse genomic DNA
(PCR primers are listed in Supplementary Table S1) and
cloned into the pGL4.14 luciferase-containing plasmid
(Promega). MEFs were plated at 7.5 10
4 cells/well in
24-well plates. Cells were transfected using FuGENE
HD reagent and a total of 850ng DNA/well consisting
of mouse Mcms (2, 5 or 7) and Pgk2 reporter constructs.
Cells were lysed in reporter lysis buffer (Promega) after
24h, and assayed for luciferase activity. Results were
standardized to the Pgk2-Luc activity levels.
Quantitative RT-PCR
Mouse embryonic ﬁbroblasts (MEFs) were seeded at
1 10
6 cells/100mm culture plate for 24h. For assaying
protein-coding genes, total RNA was isolated using
Qiagen RNeasy kits. After DNAse I (Invitrogen)
treatment, cDNA was synthesized from 1mg of total
RNA using the Invitrogen SuperScript III Reverse
Transcriptase kit in a total volume of 20ml with the
supplied Oligo-dT or random-hexamer primers. qPCR
reactions were performed in triplicate on 1ng or 10ng of
cDNA using the SYBR power green RT-PCR Master kit
(Perkin Elmer Applied Biosystems; 40 cycles at 95 C for
10s and at 60 C for 1min), and real-time detection was
performed on an ABI PRISM 7300 (Applied Biosystems)
and analyzed with the Geneamp 5700 sds program
(PerkinElmer/Applied Biosystems). The speciﬁcity of the
PCR ampliﬁcation procedures was checked with a
heat-dissociation step (from 60 Ct o9 5  C) at the end of
the run and by agarose gel electrophoresis. Results were
standardized to b-actin. The PCR primers are listed in
Supplementary Table S1.
For qPCR of microRNAs (miRNAs), total RNA prep-
arations that include RNA>18nt were puriﬁed from
MEFs using the miRNeasy Mini Kit (QIAGEN).
miRNA quantiﬁcation was performed using the qScript
microRNA Quantiﬁcation System (Quanta Biosciences).
miRNA cDNA was synthesized from 1mg of RNA using
the qScript microRNA cDNA Synthesis Kit (Quanta).
qPCR reactions were performed on ABI 7300 PRISM in
duplicate using the Power SYBR Green PCR Master Mix
(Applied Biosystems; 40 cycles at 95 C for 5s and at 60 C
for 30s). PerfeCTa microRNA Assay qPCR primers were
used (Quanta). The speciﬁcity of the qPCR reactions was
conﬁrmed with a heat-dissociation step (from 60 Ct o
95 C) added at the end of the run. Results were
standardized to RNU6.
Construction of Mcm2,3,4 mutants
Mouse DNA fragments were ampliﬁed from C3HeB/FeJ
cDNA. The Mcm4
Chaos3 allele was ampliﬁed from a
mutant homozygote. DNAs were cloned into the
pCDNA4-TO-His-Myc express plasmid (Invitrogen) for
transient transfection, and pFUW vectors for Lentiviral
infection. Mcm3 mutants were generated by site-directed
mutagenesis with the QuikChange kit (Stratagene) accord-
ing to the manufacturer’s instructions. Total sequences
were conﬁrmed after ﬁnishing the mutagenesis. The
primers used in plasmid construction are listed in
Supplementary Table S1.
Flow cytometry
For analysis of lentivirus infected cells,  1 10
6 MEFs
were trypsinized for 10min, and then washed twice with
cold PBS. They were gently but completely resuspended in
1ml of 4% paraformaldehyde in PBS at room tempera-
ture for 30min. The ﬁxed cells were pelleted by centrifu-
gation at 500g for 2min and washed twice with 10ml
TBS-TX (0.1% Triton X-100) buffer. For antibody
staining, the cells were blocked with 1ml TBS-TX buffer
with 1% BSA for 15min at room temperature, stained
with anti-Myc antibodies for 60min, washed twice and
then secondary antibody goat anti-mouse IgG-FITC
(South Biotech) with Hoechst 33258 DNA dye, which
was applied for 60min. Immunolabeled cells were
analyzed with a 488nm laser. Cells were considered to
be virus-infected if they were FITC positive. Only FITC
positive cells were used for cell cycle proﬁling as
determined by Hoechst 33258 staining of DNA content.
Calibration of the ﬂow cytometer and gates were set using
4916 Nucleic Acids Research, 2012,Vol.40, No. 11uninfected MEFs as negative controls. For ﬂow cytometry
of detergent-extracted nuclei, they were resuspended in
50ml TX-NE, ﬁxed by adding 1ml 4% PFA for 30min
on ice, pelleted at 500g for 2min, then washed twice with
10ml TBS-TX (0.1% TX-100) before staining with DAPI,
300 RNAse treatment (batches optimized empirically) and
antibody binding.
hnRNA analysis
This approach for measuring levels of primary (pre-
spliced) transcripts has been described (27,28).
RESULTS
Mcm RNA levels are regulated post-transcriptionally
The mouse Mcm4
Chaos3 allele (abbreviated ‘C3’) causes
GIN and cancer in homozygotes (8,11). Mcm4
C3/C3
MEFs have a  40% reduction in Mcm2–7mRNA
(Figure 1A and B) and protein (10,11), leading to a
decrease in dormant origins (10,11). One possible explan-
ation is differential transcription linked to altered cell
cycle in mutants. However, cell cycle proﬁles of
Mcm4
C3/C3 (‘Chaos3’) cultures have minor differences
relative to WT (10), and qRT-PCR analysis of numerous
cell-cycle regulated genes revealed only minimal (<14%)
alterations of the G1/S and S gene mRNA levels
(Figure 1A and B). Cdc6 mRNA was 24% lower
(Figure 1B), but this appears to be unrelated to the
Mcm2–7 declines; when cell cycle alterations were
rescued by Mcm3 reduction as previously described (10),
cdc6 mRNA levels but not Mcm2,4-7 mRNA levels were
restored (Figure 1C). Additionally, there was no evidence
for involvement of the E2F transcription factor family in
down-regulating Mcm2–7 transcription in Chaos3 cells,
since neither the E2F family nor key downstream targets
of E2F (Pcna, Dhfr and Ccne1/2) were down-regulated at
all or nearly as much as Mcm2–7 (Figure 1B).
Four orthogonal experiments showed that the Mcm2–7
mRNA pan-reduction occurs post-transcriptionally. First,
Mcm2–7 heterogeneous nuclear RNAs (hnRNA;
pre-spliced transcripts) were at WT levels in Chaos3
MEFs (Figure 1D). Second, luciferase reporters driven
Mcm2, Mcm5 and Mcm7 promoters in WT and Chaos3
MEFs had no signiﬁcant activity differences (Figure 1E).
Third, transcript levels of the gene trapped Mcm2
Gt and
Mcm3
Gt alleles were not decreased in Chaos3 versus WT
MEFs; in fact, the levels were actually slightly higher in
mutant cells (Figure 1F). Fourth, polymerase II occupancy
within Mcm transcriptional units in Chaos3 cells was
similar to, or higher than, that in WT cells (Figure 1G).
Mcm mRNA levels are affected by RNAi machinery,
and their decreases correlate with elevated miR-34a-c
To determine if endogenous RNAi pathways control
MCM mRNA levels, siRNA-mediated depletions of
Dicer1 and Drosha were performed in Chaos3 and control
MEFs. Dicer1 knockdown (68%) in Chaos3 MEFs was
accompanied by increase in Mcm2, 3, 4, 5 and 7 by up to
1.6-fold (Figure 2A). Drosha knockdown (72%) caused
1.3- to 1.7-fold increases of Mcm RNAs. No changes
were induced by Dicer or Drosha knockdown in WT
cells. These data are consistent with the possibility that
endogenous small RNA-mediated degradation mechan-
isms are responsible for Mcm mRNA depletion in
Chaos3 cells. Interestingly, Dicer mRNA itself also
increased upon Drosha knockdown (Figure 2A), suggest-
ing a regulatory relationship as observed by others (29).
miRNAs are an important mechanism of post-trans-
criptional modulation of gene expression, and the follow-
ing recent reports led us to suspect that miRNAs may
underlie the post-transcriptional down-regulation of
Mcms. First, conditional over-expression of miR-34a is
associated with decreased MCM2–7 protein and RNA
levels (30–32). Second, Mcm2 and Mcm5 mRNAs are
direct targets of miR-34a in the context of the RISC
complex (31). Third, the tumor suppressor TRP53,
which transcriptionally activates miR-34a-c (32), is consti-
tutively activated in Chaos3 MEFs and MCM levels
increase when Trp53 is deleted from Chaos3 cells (11).
To determine whether the miR-34 family might be
involved in post-transcriptional pan-down-regulation of
MCMs in Chaos3 MEFs, their levels were measured by
qRT-PCR. In Figure 2B, the levels of miR-34a, miR-34b
and miR-34c were increased by 145, 212 and 210%, re-
spectively. Meanwhile, the levels of three miRNAs
(miR-25, 93 and 106b) located in an Mcm7 intron were
not increased, consistent with the observation that Mcm7
transcription is unaffected in Chaos3 MEFs (Figure 1D
and E). However, there was a 20% increase in the levels
of miR-107, which is known to be up-regulated by
TRP53 (33).
The Mcm4
Chaos3 mutation disrupts MCM4:MCM6
interaction
Prior studies, and the data presented here thus far, paint
the following scenario to explain genomic instability in
Chaos3 cells: the mutation causes post-transcriptional
decreases in Mcm2–7mRNAs, which in turn decreases
MCM2–7 protein levels, leading to a reduction in
dormant replication origins. However, it is unclear what
initially triggers the reduction of Mcm mRNAs.
The Mcm4
C3 allele encodes a PHE>ILE change at a
highly conserved residue (Phe345Ile) that is predicted to
reside at the protein–protein interface region of MCM2–7
monomers (34). To explore how this mutation may initiate
the aforementioned chain of events, we considered two
possibilities. The ﬁrst is that the Chaos3 mutation
disrupts an intra-hexamer interaction(s) between MCM4
and another MCM(s). The second, based on the ﬁnding
that MCM2–7 complexes are loaded as double hexamers
into pre-RCs (35), is that inter-hexamer interactions are
disrupted in a manner that affects the loading or stability
of pre-RCs. In either scenario, the cell may sense such
defects and respond by down-regulating MCM levels.
To test these possibilities, we determined the ability of
MCM4
C3 to associate with other MCMs in HEK cells,
which are efﬁcient for transfection and expression of
exogenous constructs. Whereas MCM7 could be
co-immunoprecipitated with epitope-tagged mouse
Nucleic Acids Research, 2012,Vol.40, No. 11 4917MCM4
+or MCM4
C3, MCM6 was only pulled down with
MCM4
+ (Figure 3A). Little or no MCM2, 3 or 5 was
co-IP’d with MCM4
+ or MCM4
C3 (not shown). Similar
results were obtained with endogenous proteins in
Mcm4
C3/C3 MEFs (Figure 3B). Additionally, although
anti-MCM6 IP’d MCM7 in WT cells, it did not in
Chaos3 cells (Figure 3B). The disrupted MCM4/6 inter-
action likely causes MCM2–7 to break into subcomplexes
(Figure 3C), as was also suggested by gel ﬁltration studies
(11), and our observations of relatively weaker inter-
actions between MCM3 and MCM7 compared to
MCM3 and MCM5 (Figure 4F). Since MCM4
+ and
MCM4
C3co-IP’d each other, this suggests that the
mutation does not abolish interactions between
MCM2–7 hexamers.
Given the known relationship among MCM2–7
monomers in the intact hexamer (Figure 3B) and the dis-
rupted MCM4/6 interaction in Mcm4
C3/C3 cells, we
surmised that the already reduced MCM4
C3–MCM7
interaction becomes critical for hexamer stability, since
this link is the only one left tethering MCM4 to the rest
of the MCM2–7 complex. Consistent with this, Mcm7
heterozygosity cause a dramatic increase of micronuclei
(a metric of GIN) in Mcm4
C3/+ mice that was even
higher than in Mcm4
C3/C3 cells and all other MCM deple-
tion models (Figure 3D) (10). Notably, the genotype
Mcm4
C3/C3 Mcm7
Gt/+ causes 97% pre-wean lethality,
which is higher than all other combinations tested except-
ing homozygous nulls (10).
Rescue of MCM depletion phenotypes by genetic
reduction of MCM3 is not unique to the Chaos3 model
We previously reported the paradoxical ﬁnding that
numerous phenotypes of Chaos3 mice, the cells of which
contained  40% reduced MCM2–7 levels, were rescued
or ameliorated by further genetic reduction of MCM3
(10). These phenotypic rescues by Mcm3 heterozygosity
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Figure 1. Mcm2–7 mRNAs are reduced post-transcriptionally in Mcm4
C3/C3 MEFs. (A) Combined qRT-PCR analysis of mRNAs from various gene
classes: Mcm2–7 (MCMs); housekeeping (HK); E2F transcription factors (E2Fs); and genes involved in the indicated cell cycle stages. Individual
values for each gene within a class are shown in ‘B’. Error bars are SEM. (B) Relative levels of the indicated mRNAs in Mcm4
C3/C3 versus WT
MEFs. These are the primary data summarized in ‘A’. Genes are classiﬁed as indicated underneath the graph. Relative transcript levels were
normalized to b-actin. N=3 replicate cultures per genotype. (C) Hemizygosity for Mcm3 does not affect the levels of other Mcm mRNAs aside
from Mcm3 itself, but does increase the G1/S-expressed Cdc6 mRNA due to rescue of cell growth defects (increased G2/M and decreased G1
populations) Genotype A=Mcm4
C3/C3 Mcm2
Gt/+ Mcm3
Gt/+;B = Mcm4
C3/C3 Mcm2
Gt/+.( D) Mcm2–7 hnRNA levels in Mcm4
C3/C3 MEFs are
unchanged compared to WT. Plotted are qRT-PCR data (% WT) from intron/exon amplimers (primers listed in SI Table 1). N=3 replicates;
SEM bars are shown. (E) Mcm promoter activity is unchanged in Mcm4
C3/C3 cells. Plotted are luciferase activities in Mcm4
C3/C3 MEFs transfected
with the indicated promoter-luciferase (Prom-Luc) expression constructs (see ‘Materials and Methods’ section), with the values relative to transfec-
tions into WT MEFs. N=5 replicates; SEM bars are shown. (F) mRNA levels of Mcm2 and Mcm3 gene trap alleles in Mcm4
C3/C3 Mcm2
GT/+ and
Mcm4
C3/C3 Mcm3
GT/+ MEFs, respectively, are not decreased compared to levels in ‘Controls’: Mcm2
GT/+ and Mcm3
GT/+ MEFs, respectively. The
values are produced from qRT-PCR analysis of amplimers representing Mcm-LacZ hybrid transcripts. N=3 replicates; SEM bars are shown.
(G) ChIP-qPCR analysis of RNA Pol II occupancy within the Mcm2–7 transcription units of Mcm4
C3/C3 MEFs. Values are relative to WT, as
indicated. N=4 replicates; SEM bars are shown.
4918 Nucleic Acids Research, 2012,Vol.40, No. 11included a delay of mammary tumor onset in Mcm4
C3/C3
females and restored viability of mice bearing the
normally lethal Mcm4
C3/- genotype. Genetic reductions
of MCM2, 6 and 7 in the Mcm4
C3/C3 background
caused additional severe phenotypes (including embryonic
lethality, growth defects, anemia and early onset cancer)
that were also rescued or diminished by Mcm3
heterozygosity.
To determine if this phenomenon is unique to or
dependent upon the Chaos3 allele of Mcm4, we tested
whether MCM3 reduction could rescue the severe
phenotypes associated with a different MCM depletion
model, Mcm2
IRES-CreERT2. Mice homozygous for this
allele have 1/3 normal levels of MCM2, exhibit genomic
instability, have reduced dormant replication origins, and
most die of cancer (primarily lymphoma) at an early age
(9,36). Remarkably, Mcm3 heterozygosity signiﬁcantly
improved the 5 month survival of Mcm2
IRES-CreERT2
homozygotes (Table 1). Thus, the phenotype rescue by
MCM3 reduction applies to the circumstance of overall
MCM2–7 depletion, rather than any speciﬁc struc-
tural defects in the MCM2–7 helicase caused by the
Mcm4
Chaos3 allele, such as that resulting in the
intra-hexamer instability.
MCM3 interaction with MCM5 via a leucine-rich
motif correlates with chromatin-bound MCM levels
The rescues of genetic MCM reduction phenotypes by
Mcm3 heterozygosity was associated with increased
chromatin-bound MCMs (10), presumably improving
pre-RC density that is already decreased in Chaos3 cells
(11). We speculated that this redistribution of the
chromatin-depleted MCM pool was attributable to a
reduction in MCM3-mediated MCM2–7:XPO1 (exportin
1; the mammalian ortholog of Crm1) interaction, based on
the following observations: (i) mammalian MCM3
encodes two predicted leucine-rich potential nuclear
export signals (NES) in the same approximate location
as a functional NES in yeast Mcm3 (scMcm3) (10,37);
(ii) the scMcm3 NES interacts with Crm1 to export
Mcms through nuclear pores after DNA synthesis (37);
and (iii) MCM interaction with nuclear pore complex
(NPC) components regulates binding of MCMs to
chromatin and replication licensing in Xenopus egg
extracts (38,39).
Consistent with this hypothesis, ectopically expressed
mouse MCM3 co-IP’d XPO1 in HEK cells (Figure 4A),
whereas a mutant version in which three leucines and one
isoleucine within the predicted NES were changed to
alanines (‘L4A’; Figure 4B) abolished MCM3:XPO1 inter-
action. Over-expression of MCM3 but not MCM3
L4A in
stably transfected (via lentivirus) HeLa cells, which are
known to express very high levels of Mcms (40), caused
a decrease of chromatin-bound MCM2, 4, 5, 6 and 7
(Figure 4C; thereby increasing the soluble/chromatin
MCM ratio as plotted in Figure 4D) that was not
due to an increase of cells arrested in G2/M
(Supplementary Figure S1b). Flow cytometric analysis of
MCM2 levels in nuclei, which were decreased in G1 cells,
were consistent with the Western blot analyses
(Supplementary Figure S1a). These changes in MCM2–7
localization had functional correlates with cell growth;
over-expression of MCM3 markedly decreased colony for-
mation compared to MCM3
L4A (Figure 4C). Since CDK
phosphorylation of scMcm3 regulates its nuclear
transport ability (37), we also tested whether a presumed
phosphorylation-dead version of MCM3 (MCM3
S5A),
in which ﬁve predicted MCM3 CDK phosphorylation sites
were mutagenized (Figure 4B), lacked the ability to
increase MCM2–7 loading and improve cell growth.
This was not the case; MCM3
S5A transfection had
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Figure 2. Depletion of Mcm2–7mRNAs in Mcm4
C3/C3 cells is Dicer1
and Drosha-regulated, and associated with up-regulation of micro
RNAs miR-34a-c. (A) The graphs showed qRT-PCR analysis of the
indicated genes in Mcm4
C3/C3 or WT MEFs that were treated with
siRNA against Dicer1 (top) and Drosha (bottom) for 120h. N=3 rep-
licates; SEM bars are shown. Data were standardized against b-actin.
(B) qRT-PCR analysis of various miRNAs. The values are plotted as
percentages of the levels of the indicated miRNAs in Mcm4
C3/C3
(Chaos3) MEFs versus WT MEFs. The data represent analysis of
5 littermate pairs of MEFs. SEM bars are shown.
Nucleic Acids Research, 2012,Vol.40, No. 11 4919effects similar to the WT construct (Figures 4E, 5A and
B). Furthermore, dephosphorylation of protein extracts
did not disrupt MCM3:XPO1 interaction (Figure 4A),
suggesting that the anti-licensing effects of MCM3 may
occur via a mechanism not involving, or in addition to,
XPO1 interaction. We posit that the anti-licensing activity
of MCM3 might involve interaction of another protein
with the leucine-rich domain.
In mammalian cells, MCM3 dimerizes robustly with
MCM5(41,42).ItalsobindsMCM7,butwithlowerafﬁnity
(41). To determine if the leucine-rich motifs in MCM3
mediate these interactions, the abilities of MYC-tagged
MCM3 and MCM3
L4A to bind these partners were
compared in co-IP experiments. As expected, WT MCM3
bound both MCM5 and MCM7, but the L4A mutation
completely abolished interaction with MCM5 speciﬁcally
(Figure 4F). Although CDK-dependent phosphorylation
of speciﬁc MCM3 S/T sites was reported to stimulate its
binding to other MCMs (including MCM5 and MCM7)
and loading onto chromatin (41), MCM3
S5A maintained
strong interactions with MCM5 and MCM7 despite
having mutations of these same S/T sites (Figure 4F).
MCM3 modulates cell cycle dynamics by controlling
MCM2–7 loading onto chromatin
To investigate MCM3’s apparent role as a negative cell
cycle regulator, we utilized primary MEFs that exhibit
well-characterized phenotypes arising from genetic Mcm
depletion. Chaos3 MEFs, with  60% WT MCM2–7
levels, exhibit a mild accumulation of G2/M stage cells
(8,10). Further genetic reduction of MCM2 to  17%
WT levels (in Mcm4
C3/C3 Mcm2
Gt/+ cells) severely
impacted cell growth and viability of mice (10). Cells of
this genotype had a 37% increased G2/M population, in-
dicative of cell cycle arrest (Figure 5A). Further genetic
reduction of MCM3 (Mcm4
C3/C3 Mcm2
Gt/+ Mcm3
Gt/+),
which was shown to partially rescue the poor growth
and early senescence of Mcm4
C3/C3 Mcm2
Gt/+ MEFs by
increasing MCM binding to chromatin (10), signiﬁcantly
decreased the degree of G2/M arrest (Figure 5A). Mice of
this genotype do not suffer the extreme embryonic lethal-
ity as do Mcm4
C3/C3 Mcm2
GT/+ animals.
These results predict that increasing MCM3 (above
haploinsufﬁcient level) would inhibit cell growth in this
model system, but added expression of other MCMs
would rescue growth. Indeed, cells expressing ectopic
Mcm2 or Mcm4 expression rescued the G2/M delay
(Figure 5B and C), while expression of WT Mcm3 (or
MCM3
S5A) aggravated the G2/M arrest. In contrast,
expression of MCM3
L4A rescued the G2/M arrest even
more efﬁciently than Mcm2 or Mcm4 (Figure 5B), sug-
gesting that this protein improves MCM2–7 function or
formation, but that the disrupted interaction with MCM5
and/or XPO1 speciﬁcally obliterates the negative regula-
tory role of MCM3.
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The mechanisms of pre-RC establishment, activation and
inhibition have been studied intensely. Fewer studies are
how diverse cells in complex organisms modulate overall
origin licensing levels. Using a genetic approach, we
uncover two novel post-transcriptional phenomena that
coordinate and adjust MCM levels in mice and primary
cells, and relate these to in vivo consequences.
Most unexpected was the coordinate post-trans-
criptional down-regulation of Mcm mRNA in Chaos3
cells. Two likely mechanisms are: (i) decreased mRNA
stability; or (ii) active mRNA degradation. Since Dicer1
or Drosha knockdown increased Mcm2–7 mRNA levels in
Chaos3 cells, this lends support for the latter, and suggests
that miRNAs are involved. We hypothesized that if this
were the case, that one miRNA might bind all the Mcm2–
7 mRNAs. However, while there are numerous predicted
binding sites (www.targetscan.org) for known miRNAs in
the 30-UTRs of each mRNA, no single one is predicted to
Figure 4. MCM3 interacts with XPO1 and MCM5 via an NES motif that is essential for inhibiting MCM chromatin binding and cell proliferation.
(A) MCM3 interacts with XPO1 in an NES-dependent manner. Shown are Western blots probed for proteins co-IP’d from HEK cells ectopically
expressing MYC tagged mMCM3 (M3) or a version with four Leucines mutated within the putative NES (M3-L4A; see ‘B’). The middle lane
contains extracts that treated with calf intestinal alkaline phosphatase (CIAP) prior to IP. (B) Schematic of mutation made in the putative NES motif
(top) and CDK phosphorylation sites (bottom) within MCM3. (C) Western blot analysis of the indicated chromatin-bound (‘Extracted’) and soluble
proteins isolated from HeLa cells infected with control (LacZ vector) or MYC-tagged MCM3 lentiviral constructs (listed at top). (D) Quantiﬁcation
of Western blot data by densitometry. Intensities of bands in ‘A’ were normalized against GAPDH in soluble fractions, or ﬁbrillarin in extracted
fractions. These values relative to WT cells are plotted. Experiments were repeated twice. (E) Images of HeLA cell culture plates (crystal violet
stained) infected with lentiviruses expressing control (LacZ) or the indicated MCM3 proteins variants. (F) MCM3 interacts with MCM5 via the NES
motif. HeLa cells were transduced with vectors expressing MYC-tagged LacZ, MCM3
WT, MCM3
L4A or MCM3
S5A, immunoprecipitated (right
panel), and probed for MCM3, MCM5 or MCM7.
Table 1. Mcm3 heterozygosity improves survival of Mcm2
IRES-CreERT2
homozygotes
Genotype >3 month
survival
>5 month
survival
Mcm2
+/+ Mcm3
+/+ 14/14 9/9
Mcm2
+/+ Mcm3
Gt/+ 12/12 10/10
Mcm2
IRES-CreERT2/IRES-CreERT2 Mcm3
+/+ 9/16 1/6
Mcm2
IRES-CreERT2/IRES-CreERT2 Mcm3
Gt/+ 12/15 7/8*
*Signiﬁcantly different from genotype above (P=0.0256; Fisher’s exact
test).
Nucleic Acids Research, 2012,Vol.40, No. 11 4921bind all of them. This raised several alternate possibilities
including: (i) the miRNA-mediated regulation is indirect;
(ii) multiple miRNAs are involved; and (iii) the culprit
miRNAs do not bind the 30-UTRs.
As described earlier, recent evidence implicated involve-
ment of the miR-34 family. miR-34a over-expression
causes decreased MCM2–7 protein and RNA levels
despite not having 30-UTR seed sequences (30,31), and
both Mcm2 and Mcm5 mRNAs were found to be
associated with miR-34a in the RISC complex (31). Our
ﬁnding that each of the miR-34 members are strikingly
elevated in Chaos3 MEFs is not only consistent with
their being involved in the Mcm2–7mRNA depletion phe-
nomenon, but since miR-34b and miR-34c are more
highly elevated than miR-34a in the mutant cells, the
former two may play a leading role in suppressing
MCM2–7 levels. Over-expression of miR-34a-c each
decrease levels of Mcm3 and 5 mRNAs (32). Other than
the direct effects known for miR-34a upon Mcm2 and
Mcm5, the relationships between the 6Mcms and the
miR-34 family members remain uncertain.
Besides the actual mechanism by which Mcm mRNAs
are down-regulated, a key question concerns the trigger of
the mechanism. In the case of Mcm4
C3, the trigger is likely
one or more of the downstream consequences of Phe345Ile
mutation. These include disrupted MCM4–MCM6 inter-
action (Figure 3A–C), elevated DSBs and replication fork
stalling that persists into G2/M and triggers DNA damage
responses (11). However, the latter is hypothesized to be a
consequence of reduced dormant origins (11), a condition
that presumably results from the mRNA reductions
demonstrated here, and therefore would be downstream
of the initial trigger. While the precise trigger remains
unclear, we hypothesize that TRP53 signaling is central.
TRP53 directly stimulates miR-34a-c transcription (32), is
constitutively activated in Mcm4
C3/C3 MEFs, and MCM
levels increase when Trp53 is deleted from Mcm4
C3/C3 cells
(43). Although elevated TRP53 can repress Mcm tran-
scription (44), this is not occurring in Chaos3 cells.
Perhaps TRP53 is a more potent transcriptional activator
of miRNA-34 than a repressor of Mcms.
Although Mcm2–7mRNA depletion must be down-
stream of a trigger caused by the Chaos3 mutation, it is
possible that MCM depletion alone, if sufﬁcient to cause
replication stress, can elicit the same response. Although
50% genetic reduction of Mcm4 or Mcm6 in MEFs did
not cause a decrease in the other Mcm mRNAs, hetero-
zygosity for Mcm2 did cause a minor pan-reduction
ranging from 10% to 20% (10) (C.-H. Chuang, unpub-
lished observations). Interestingly, there are reports in
the literature indicative of coordinated Mcm pan-
reduction mechanisms, but that the phenomena are
complicated, and may vary according to organism,
system and particular MCM. Numerous studies have
reported MCM protein decreases in response to
mutation or knockdown of a single MCM, including
Drosophila (15) and human cells (4,13,41). In these
examples of parallel MCM decreases, the general assump-
tion is that there is hexamer destabilization or impaired
loading followed by degradation of MCM monomers.
This may, indeed, be true in some cases, but mRNA
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Figure 5. Defective cell cycle in MCM-deﬁcient cells and impact of WT
or mutant MCM3 levels. (A) Flow cytometric analysis of cell cycle in
unsynchronized MEFs. The values are plotted as a percentage of the
measured average of Mcm4
Chaos3/Chaos3 MEFs for each cell cycle stage
(Y-axis), which is set to 100%. The MEFs were established from
littermates. ‘C3’=Mcm4
Chaos3; ‘M#’=Mcm#; ‘GT’ is shorthand for
the mutant allele of that Mcm. Error bars represent SEM, derived from
at least 14 independent experiments (‘N’ numbers indicated). ‘*’=stat-
istically signiﬁcant to P<0.05). (B) Cell cycle histograms of Mcm
C3/C3
Mcm2
+/  Mcm3
+/  MEFs infected with lentiviruses expressing the
either LacZ alone (‘CON’) or the indicated Mcm. Only infected cells
were scored, based on expression of epitope tags. (C) Quantiﬁcation of
G2/M population data (gates are shown in ‘B’). The percentages of G2/
M population were normalized against LacZ controls (set to 100%).
Error bars represent SEM from three independent experiments.
4922 Nucleic Acids Research, 2012,Vol.40, No. 11levels were rarely assessed. Interestingly, an opposite regu-
latory phenomenon has been observed such that over-
expression of certain exogenous Mcms in CHO cells
caused a compensatory decreased in the corresponding
endogenous protein (45). However, the basis for this was
not explored.
The second post-transcriptional regulatory mechanism
we found is that MCM3:MCM5 interaction blocks
MCM2–7 loading onto chromatin in vivo, and that alter-
ation of MCM3 levels has phenotypic consequences in par-
allel with the effects upon MCM loading. These results
support data from in vitro studies that the function of
this pair is regulatory in nature (21). Regarding the
exact mechanism behind the inhibitory role of MCM3,
we suggest that free MCM3 and/or MCM3:MCM5 de-
creases the amounts of their adjacent partners (MCM7
and MCM5 for MCM3; MCM2 and MCM3 for
MCM5) that are available for heterohexamer formation.
Supportive of this idea is a study indicating that there may
be 2–3 times more MCM3 than each of the other 5MCMs
(46,47). Since MCM3
L4A lacks negative effects on
MCM2–7 loading but retains the ability to interact with
MCM7, the obstructive effect would be dependent on
interaction with MCM5. Our ﬁnding that MCM3 inter-
acts with XPO1 via an NES consensus sequence raises the
possibility that the MCM3:5 binding occurs in the context
of nuclear pore association. However, it is unclear if
nuclear export of MCM2–7 is mediated by this inter-
action. Interestingly, the nuclear pore complex (NPC)
protein ELYS, which interacts with MCM2 and 4, is im-
portant for maintaining normal levels of dormant origins
in mouse intestinal cells (48), suggesting that the NPC is
an important site at which MCM licensing is governed
both positively and negatively.
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